Search

Author/Creator Armstrong, April

3. Baricitinib 2 mg for the treatment of atopic dermatitis in North America: Long‐term efficacy and patient‐reported outcomes. Issue 12 (4th November 2022)

Authors:
Simpson, Eric; Armstrong, April; Boguniewicz, Mark; Chiesa Fuxench, Zelma C.; Feely, Meghan; Pierce, Evangeline; Sun, Luna; Chen, Yun‐Fei; Angle, Robinette; Silverberg, Jonathan I.
Journal:
Dermatologic therapy
Issue:
Volume 35:Issue 12(2022)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Bimekizumab versus ustekinumab for the treatment of moderate to severe plaque psoriasis (BE VIVID): efficacy and safety from a 52-week, multicentre, double-blind, active comparator and placebo controlled phase 3 trial. Issue 10273 (6th February 2021)

Authors:
Reich, Kristian; Papp, Kim A; Blauvelt, Andrew; Langley, Richard G; Armstrong, April; Warren, Richard B; Gordon, Kenneth B; Merola, Joseph F; Okubo, Yukari; Madden, Cynthia; Wang, Maggie; Cioffi, Christopher; Vanvoorden, Veerle; Lebwohl, Mark
Journal:
Lancet
Issue:
Volume 397:Issue 10273(2021)
Page Start:
487
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Biosimilars in Dermatology: Analytical, Regulatory, and Clinical Considerations: A Treatise From the Medical Board of the National Psoriasis Foundation. Issue 3 (July 2019)

Authors:
Yamauchi, Paul S.; Sachsman, Suzanne M.; Wu, Jashin J.; Siegel, Michael; Van Voorhees, Abby; Armstrong, April; Kay, Jonathan
Journal:
Journal of psoriasis and psoriatic arthritis
Issue:
Volume 4:Issue 3(2019)
Page Start:
125
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Comparative cost-effectiveness of tildrakizumab and other commonly used treatments for moderate-to-severe psoriasis. (3rd October 2021)

Authors:
Wu, Jashin J.; Jia, Xiaoying; Zhao, Yang; Carrico, Justin; Brodtkorb, Thor-Henrik; Mendelsohn, Alan; Lowry, Simon; Feldman, Steven R.; Armstrong, April
Journal:
Journal of dermatological treatment
Issue:
Volume 32:Number 7(2021)
Page Start:
693
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Dietary supplementation with Bifidobacterium longum subsp. infantis (B. infantis) in healthy breastfed infants: study protocol for a randomised controlled trial. Issue 1 (December 2016)

Authors:
Awasthi, Smita; Wilken, Reason; Patel, Forum; German, J.; Mills, David; Lebrilla, Carlito; Kim, Kyoungmi; Freeman, Samara; Smilowitz, Jennifer; Armstrong, April; Maverakis, Emanual
Journal:
Trials
Issue:
Volume 17:Issue 1(2016)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and depression, and health-related quality of life in moderate-to-severe atopic dermatitis: analysis of pooled data from the randomized trials SOLO 1 and SOLO 2. (17th August 2020)

Authors:
Cork, Michael J.; Eckert, Laurent; Simpson, Eric L.; Armstrong, April; Barbarot, Sébastien; Puig, Luis; Girolomoni, Giampiero; de Bruin-Weller, Marjolein; Wollenberg, Andreas; Kataoka, Yoko; Remitz, Anita; Beissert, Stefan; Mastey, Vera; Ardeleanu, Marius; Chen, Zhen; Gadkari, Abhijit; Chao, Jing...
Journal:
Journal of dermatological treatment
Issue:
Volume 31:Number 6(2020)
Page Start:
606
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗